Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects
This open-label study (n=15) assessed the association between resting-state time-varying functional connectivity (tvFC) characteristics and plasma psilocin level (PPL) and subjective drug intensity (SDI) before and right after psilocybin intake (21mg/70kg). Findings suggest that the effects induced by psilocybin may stem from drug-level-associated decreases in the occurrence and duration of lateral and medial frontoparietal connectivity motifs.
Authors
- Gitte Knudsen
- Patrick Fisher
- Dea Stenbæk
Published
Abstract
Background
Psilocin, the neuroactive metabolite of psilocybin, is a serotonergic psychedelic that induces an acute altered state of consciousness, evokes lasting changes in mood and personality in healthy individuals, and has the potential as an antidepressant treatment. Examining the acute effects of psilocin on resting-state time-varying functional connectivity implicates network-level connectivity motifs that may underlie acute and lasting behavioural and clinical effects.
Aim
Evaluate the association between resting-state time-varying functional connectivity (tvFC) characteristics and plasma psilocin level (PPL) and subjective drug intensity (SDI) before and right after intake of a psychedelic dose of psilocybin in healthy humans.
Methods
Fifteen healthy individuals completed the study. Before and at multiple time points after psilocybin intake, we acquired 10-minute resting-state blood-oxygen-level-dependent functional magnetic resonance imaging scans. Leading Eigenvector Dynamics Analysis (LEiDA) and diametrical clustering were applied to estimate discrete, sequentially active brain states. We evaluated associations between the fractional occurrence of brain states during a scan session and PPL and SDI using linear mixed-effects models. We examined associations between brain state dwell time and PPL and SDI using frailty Cox proportional hazards survival analysis.
Results
Fractional occurrences for two brain states characterized by lateral frontoparietal and medial fronto-parietal-cingulate coherence were statistically significantly negatively associated with PPL and SDI. Dwell time for these brain states was negatively associated with SDI and, to a lesser extent, PPL. Conversely, fractional occurrence and dwell time of a fully connected brain state partly associated with motion was positively associated with PPL and SDI.
Conclusion
Our findings suggest that the acute perceptual psychedelic effects induced by psilocybin may stem from drug-level associated decreases in the occurrence and duration of lateral and medial frontoparietal connectivity motifs. We apply and argue for a modified approach to modelling eigenvectors produced by LEiDA that more fully acknowledges their underlying structure. Together these findings contribute to a more comprehensive neurobiological framework underlying acute effects of serotonergic psychedelics.
Research Summary of 'Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects'
Introduction
Psilocybin, via its active metabolite psilocin and agonism at the serotonin 2A receptor (5-HT2AR), produces acute alterations of consciousness and rapid, sometimes lasting, changes in mood and cognition. Previous resting-state fMRI studies report broad alterations in thalamic and whole-brain connectivity, reduced segregation among canonical networks, and increased signal complexity, but most work has used “static” functional connectivity estimated across an entire scan and thus may miss rapidly evolving neural dynamics that accompany the psychedelic experience. This study set out to characterise acute psilocybin effects on time-varying functional connectivity (tvFC) during the extended oral psilocybin experience, and to relate those dynamics to measured plasma psilocin level (PPL) and subjective drug intensity (SDI). Olsen and colleagues applied Leading Eigenvector Dynamics Analysis (LEiDA) to instantaneous phase-coherence estimates from BOLD rs-fMRI and introduced diametrical clustering (a method that respects the antipodal spherical geometry of normalised eigenvectors) to define discrete brain states. They also modelled state dwell time using survival analysis (Cox frailty models) rather than simple averages, and explored robustness across a range of cluster numbers (k = 2–20). The primary goal was to map brain-state fractional occurrence and dwell time onto PPL and SDI during the psilocybin session.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Olsen, A. S., Lykkebo-Valløe, A., Ozenne, B., Madsen, M. K., Stenbæk, D. S., Armand, S., Mørup, M., Ganz, M., Knudsen, G. M., & Fisher, P. M. (2022). Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects. NeuroImage, 264, 119716. https://doi.org/10.1016/j.neuroimage.2022.119716
References (31)
Papers cited by this study that are also in Blossom
Barrett, F. S., Doss, M. K., Sepeda, N. D. et al. · Scientific Reports (2020)
Bogenschutz, M. P., Ross, S., Bhatt, S. R. et al. · JAMA Psychiatry (2022)
Carhart-Harris, R. L., Bolstridge, &. M., Day, C. M. J. et al. · Psychopharmacology (2017)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Carhart-Harris, R. L., Roseman, L., Bolstridge, M. et al. · Scientific Reports (2017)
Davis, A. K., Barrett, F. S., May, D. G. et al. · JAMA Psychiatry (2021)
Doss, M. K., Považan, M., Rosenberg, M. D. et al. · Translational Psychiatry (2021)
Erritzoe, D., Roseman, L., Nour, M. R. et al. · Acta Psychiatrica Scandinavica (2018)
Show all 31 referencesShow fewer
Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Hasler, F., Grimberg, U., Benz, M. A. et al. · Psychopharmacology (2004)
Kringelbach, M. L., Cruzat, J., Cabral, J. et al. · PNAS (2020)
Lord, L. D., Expert, P., Atasoy, S. et al. · NeuroImage (2019)
Luppi, A. I., Carhart-Harris, R. L., Roseman, L. et al. · NeuroImage (2021)
Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)
Madsen, M. K., Fisher, P. M., Burmester, D. et al. · Neuropsychopharmacology (2019)
Madsen, M. K., Fisher, P. M., Stenbæk, D. S. et al. · European Neuropsychopharmacology (2020)
Madsen, M. K., Stenbaek, D. S., Arvidsson, A. et al. · European Neuropsychopharmacology (2021)
Mason, N. L., Kuypers, K. P. C., Reckweg, J. et al. · Neuropsychopharmacology (2020)
McCulloch, D. E-W., Knudsen, G. M., Barrett, F. S. et al. · Neuroscience and Biobehavioral Reviews (2022)
McCulloch, D. E-W., Madsen, M. K., Stenbæk, D. S. et al. · Journal of Psychopharmacology (2021)
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J. et al. · Journal of Neuroscience (2013)
Preller, K. H., Burt, J. B., Adkinson, B. et al. · Biological Psychiatry (2020)
Preller, K. H., Razi, A., Zeidman, P. et al. · PNAS (2019)
Schindler, E. A. D., Sewell, R. A., Gottschalk, C. H. et al. · Neurotherapeutics (2021)
Sewell, R. A. · Neurology (2006)
Stenbæk, D. S., Madsen, M. K., Ozenne, B. et al. · Journal of Psychopharmacology (2020)
Vargas, A. S., Luís, Â., Barroso, M. et al. · Biomedicines (2020)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Cited By (4)
Papers in Blossom that reference this study
Larsen, K., Lindberg, U., Ozenne, B. et al. · Journal of Cerebral Blood Flow and Metabolism (2025)
Lewis, E. C., Jaeger, A., Girn, M. et al. · Journal of Psychopharmacology (2024)
Mortaheb, S., Fort, L. D., Mason, N. L. et al. · Biological Psychiatry (2023)
McCulloch, D. E-W., Olsen, A. S., Ozenne, B. et al. · MedRvix (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.